1. Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis. (24th August 2021) Authors: de Botton, Stéphane; Brandwein, Joseph M.; Wei, Andrew H.; Pigneux, Arnaud; Quesnel, Bruno; Thomas, Xavier; Legrand, Ollivier; Recher, Christian; Chantepie, Sylvain; Hunault‐Berger, Mathilde; Boissel, Nicolas; Nehme, Salem A.; Frattini, Mark G.; Tosolini, Alessandra; Marion‐Gallois, Roland; Wang,... Journal: Cancer medicine Issue: Volume 10:Number 18(2021) Page Start: 6336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗